Lars Dyrskjøt

发表

Identifying distinct classes of bladder carcinoma using microarrays

Torben F. Ørntoft, Mogens Kruhøffer, Jens Ledet Jensen, 2003, Nature Genetics.

Alternative Splicing in Colon, Bladder, and Prostate Cancer Identified by Exon Array Analysis*S

Anne-Mette K. Hein, Søren Brunak, Karina D. Sørensen, 2008, Molecular & Cellular Proteomics.

Chromosomal deletion, promoter hypermethylation and downregulation of FYN in prostate cancer

K. D. Sørensen, Michael Borre, Torben Falck Ørntoft, 2008, International journal of cancer.

Multicenter validation of cyclin D1, MCM7, TRIM29, and UBE2C as prognostic protein markers in non-muscle-invasive bladder cancer.

Per-Uno Malmström, Chin-Chen Pan, Michael Borre, 2013, The American journal of pathology.

Emmprin and Survivin Predict Response and Survival following Cisplatin-Containing Chemotherapy in Patients with Advanced Bladder Cancer

Torben F. Ørntoft, Jens L. Jensen, Francisco Mansilla, 2007, Clinical Cancer Research.

Expression of TIP60 (tat‐interactive protein) and MRE11 (meiotic recombination 11 homolog) predict treatment‐specific outcome of localised invasive bladder cancer

Arndt Hartmann, Rainer Fietkau, Michael Borre, 2012, BJU international.

MicroRNA profiles of prostate carcinoma detected by multiplatform microRNA screening

Arif B Ekici, Arndt Hartmann, Elke Eltze, 2012, International journal of cancer.

Gene Expression in the Urinary Bladder

Mogens Kruhøffer, T. Ørntoft, M. Kruhøffer, 2004, Cancer Research.

Role of Activating Fibroblast Growth Factor Receptor 3 Mutations in the Development of Bladder Tumors

Carsten Wiuf, Torben Falck Ørntoft, T. Ørntoft, 2005, Clinical Cancer Research.

Comprehensive Genome Methylation Analysis in Bladder Cancer: Identification and Validation of Novel Methylated Genes and Application of These as Urinary Tumor Markers

Carsten Wiuf, Torben F. Ørntoft, Philippe Lamy, 2011, Clinical Cancer Research.

Exosomes of invasive urothelial carcinoma cells are characterized by a specific miRNA expression signature

Rainer Bohle, Michael Stöckle, R. Bohle, 2017, Oncotarget.

Tumour exosomes display differential mechanical and complement activation properties dependent on malignant state: implications in endothelial leakiness

Seyed Moein Moghimi, M. Dong, L. Dyrskjøt, 2015, Journal of extracellular vesicles.

Coordinated epigenetic repression of the miR‐200 family and miR‐205 in invasive bladder cancer

Jørgen Kjems, Michael Borre, Jesper B Bramsen, 2011, International journal of cancer.

Optimized targeted sequencing of cell-free plasma DNA from bladder cancer patients

Jakob Skou Pedersen, Søren Vang, J. S. Pedersen, 2018, Scientific Reports.

Tumor-specific usage of alternative transcription start sites in colorectal cancer identified by genome-wide exon array analysis

Carsten Wiuf, Jakob Skou Pedersen, Søren Vang, 2011, BMC Genomics.

Genomic profiling of microRNAs in bladder cancer: miR-129 is associated with poor outcome and promotes cell death in vitro.

Jørgen Kjems, Philippe Lamy, Michael Borre, 2009, Cancer research.

Alternative Splicing of SLC39A14 in Colorectal Cancer is Regulated by the Wnt Pathway*

Adrian R. Krainer, Claus L. Andersen, Torben F. Ørntoft, 2010, Molecular & Cellular Proteomics.

High miR-449b expression in prostate cancer is associated with biochemical recurrence after radical prostatectomy

K. D. Sørensen, Søren Høyer, Michael Borre, 2014, BMC Cancer.

Circular RNA expression is abundant and correlated to aggressiveness in early-stage bladder cancer

Jakob Skou Pedersen, Søren Vang, Morten Muhlig Nielsen, 2017, npj Genomic Medicine.